Evaluation of Serum and Urinary Angiogenic Factors in Patients with Endometriosis
- 9 November 2007
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 58 (6), 497-504
- https://doi.org/10.1111/j.1600-0897.2007.00535.x
Abstract
Problem The aim of this study was to evaluate serum and urinary levels of vascular endothelial growth factors, tumor necrosis factor‐α (TNF‐α), and soluble fms‐like tyrosine kinase (sFlt‐1) in patients with endometriosis. Method of study During surgery for pelvic pain, pelvic mass or infertility, serum and urine were collected. Of 70 patients, 46 had histology‐proven endometriosis and 24 patients without endometriosis participated as controls. Results Serum TNF‐α levels and urinary sFlt‐1 levels corrected for creatinine excretion were significantly increased in the endometriosis group (P = 0.001 and P = 0.011 respectively). Serum sFlt‐1 levels and urinary sFlt‐1 levels corrected for creatinine were significantly higher in patients with minimal‐to‐mild disease (P = 0.014 and P = 0.015 respectively), where serum TNF‐α levels were increased in moderate‐to‐severe endometriosis (P < 0.001). Conclusion The pathogenesis of minimal‐to‐mild endometriosis and moderate‐to‐severe endometriosis seems to be different. Increased sFlt‐1 levels in serum and urine of minimal‐to‐mild disease indicate that sFlt‐1 may have an important role in inhibiting angiogenic process of the disease.Keywords
This publication has 25 references indexed in Scilit:
- Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out comeHematology, 2005
- Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2005
- Expression of interleukin-8 receptors in endometriosisHuman Reproduction, 2005
- Soluble TNF‐α and interleukin‐6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levelsEuropean Journal of Heart Failure, 2004
- Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer typesClinical Biochemistry, 2004
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosisHuman Reproduction, 2003
- Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumoursHuman Reproduction, 2003
- Different response of urinary excretion of VEGF in patients with chronic and acute renal failureKidney International, 2001
- Tumor Necrosis Factor- Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein ExpressionJournal of Clinical Endocrinology & Metabolism, 2000
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997